Methods of treating hematologic cancers using PNP inhibitors such as forodesine in combination with alkylating agents or anti-CD20 agents

Details for Australian Patent Application No. 2008335167 (hide)

Owner BioCryst Pharmaceuticals, Inc.

Inventors Babu, Yarlagadda S.; Bantia, Shanta; Breitfeld, Philip

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008335167

PCT Pub. Number WO2009/076455

Priority 61/012,762 10.12.07 US

Filing date 10 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 31/4184 (2006.01)

A61K 31/4745 (2006.01)

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076455 Priority application(s): WO2009/076455

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335170-Television traffic estimation

2008335158-LNG facility employing a heavies enriching stream